论文部分内容阅读
Objective The aim of this study was to investigate the clinical efficacy of neoadjuvant chemotherapy (NACT) and the prognostic factors for advanced epithelial ovarian cancer (EOC). Methods We enrolled 241 patients with stage III and IV EOC who were diagno